Your Good Partner in Biology Research

Human Immunoglobulin G(IgG)ELISA Kit

  • 中文名稱:
    人免疫球蛋白G(IgG)酶聯(lián)免疫試劑盒
  • 貨號(hào):
    CSB-E07979h
  • 規(guī)格:
    96T/48T
  • 價(jià)格:
    ¥3200/¥2500
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品描述:
        免疫球蛋白G(IgG)是由人體內(nèi)部的免疫細(xì)胞分泌的抗體,它主要通過與抗原的結(jié)合來調(diào)節(jié)和清除病原體,從而發(fā)揮免疫保護(hù)作用。在多種疾病中,IgG水平的檢測(cè)可作為診斷、治療和預(yù)后判斷的重要參考指標(biāo)。
        華美生物所提供的Human Immunoglobulin G(IgG)ELISA Kit屬于ELISA檢測(cè)試劑盒,采用競(jìng)爭(zhēng)法定量檢測(cè)人血清、血漿、細(xì)胞培養(yǎng)上清、尿液、組織勻漿、細(xì)胞裂解液樣本中的IgG,其靈敏度為0.487 μg/mL,檢測(cè)范圍為0.59 μg/mL-150 μg/mL。
     
  • 別名:
    N/A
  • 縮寫:
    IgG
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum, plasma, cell culture supernates, urine, tissue homogenates, cell lysates
  • 檢測(cè)范圍:
    0.59 μg/mL-150 μg/mL
  • 靈敏度:
    0.487 μg/mL
  • 反應(yīng)時(shí)間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測(cè)波長(zhǎng):
    450 nm
  • 研究領(lǐng)域:
    Immunology
  • 測(cè)定原理:
    quantitative
  • 測(cè)定方法:
    Competitive
  • 精密度:

     

    Intra-assay Precision (Precision within an assay): CV%<8%

    Three samples of known concentration were tested twenty times on one plate to assess.

    Inter-assay Precision (Precision between assays): CV%<10%

    Three samples of known concentration were tested in twenty assays to assess.

     

  • 線性度:

     

    To assess the linearity of the assay, samples were spiked with high concentrations of human IgG in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.

     

  • 標(biāo)準(zhǔn)曲線:

     

    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

     

  • 數(shù)據(jù)處理:
  • 貨期:
    3-5 working days

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

  • 最新研究進(jìn)展:
    IgG是一種重要的免疫球蛋白,它在機(jī)體的免疫應(yīng)答中發(fā)揮著重要作用。近年來,越來越多的研究關(guān)注了IgG的多樣性、功能和臨床應(yīng)用,特別是在腫瘤免疫治療、自身免疫病和傳染病等領(lǐng)域。例如,一些研究表明,IgG亞型的選擇性變化可能與自身免疫病的發(fā)生和發(fā)展有關(guān);另外,IgG的抗體依賴性細(xì)胞毒性也被證明在腫瘤免疫治療中發(fā)揮著重要作用。此外,IgG的工程化改造也為開發(fā)新型抗體藥物提供了新思路和新平臺(tái)。